A POPULATION AND FAMILY STUDY OF N-ACETYLTRANSFERASE USING CAFFEINE URINARY METABOLITES

被引:51
作者
BECHTEL, YC
BONAITIPELLIE, C
POISSON, N
MAGNETTE, J
BECHTEL, PR
机构
[1] CHU JEAN MINJOZ, SERV PHARMACOL CLIN, F-25030 BESANCON, FRANCE
[2] INSERM, UNITE RECH EPIDEMIOL GENET, U155, F-75005 PARIS, FRANCE
关键词
D O I
10.1038/clpt.1993.124
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Population and family studies were undertaken to validate caffeine as a probe drug to establish the genetic status of rapid acetylators and slow acetylators. The acetylator status was established from the urinary metabolic ratio of 5-acetylamino-6-formylamino-3-methyluracil to 1-methylxanthine (AFMU/1X) after oral administration of caffeine. We confirmed a bimodal distribution (chi(1)2 = 229.48; p < < 10(-9)) of the AFMU/1X ratio in 245 unrelated subjects. A third distribution did not significantly improve the fit to the data (chi(1)2 = 0.04; p = 0.84). Complex segregation analysis of 76 nuclear families confirmed the monogenic inheritance of N-acetyltransferase, with incomplete dominance of the rapid allele over the slow one. We observed a slight shift between the mean activities of heterozygous and homozygous rapid acetylators (t = 2.89; p < 0.01). However, the 30 obligate heterozygotes belonging to the 76 families were evenly distributed among the rapid acetylators and never located in a hypothetic intermediary group between slow acetylators and rapid acetylators.
引用
收藏
页码:134 / 141
页数:8
相关论文
共 26 条
[1]  
BECHTEL PR, 1990, EUROPEAN C PHARMACOG, V1
[2]   MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS [J].
BLUM, M ;
DEMIERRE, A ;
GRANT, DM ;
HEIM, M ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5237-5241
[3]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[4]   SENSITIVITY OF TRANSMISSION PROBABILITIES TO PATERNITY EXCLUSION IN SEGREGATION ANALYSIS [J].
BONAITIPELLIE, C ;
POISSON, N ;
BECHTEL, Y ;
BECHTEL, P .
GENETIC EPIDEMIOLOGY, 1992, 9 (01) :67-71
[5]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[6]  
EVANS DAP, 1989, PHARMACOL THERAPEUT, V42, P157
[7]   GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].
EVANS, DAP ;
MANLEY, KA ;
MCKUSICK, VA .
BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491
[8]   PREDICTION OF PHENOTYPE FOR ACETYLATION AND FOR DEBRISOQUINE HYDROXYLATION BY DNA-TESTS IN HEALTHY-HUMAN VOLUNTEERS [J].
GRAF, T ;
BROLY, F ;
HOFFMANN, F ;
PROBST, M ;
MEYER, UA ;
HOWALD, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) :399-403
[9]   VARIABILITY IN CAFFEINE METABOLISM [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :591-602
[10]   A SIMPLE TEST FOR ACETYLATOR PHENOTYPE USING CAFFEINE [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :459-464